Patents by Inventor Yulia Matiuhin

Yulia Matiuhin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE
    Publication number: 20220152132
    Abstract: Disclosed herein are bacteriophage compositions and therapeutic uses thereof. The disclosure also relates to bacteriophage that are capable of lysing Klebsiella bacterial strains, e.g., strains that are associated with inflammatory bowel disease, and thereby capable of modulating disease.
    Type: Application
    Filed: March 6, 2020
    Publication date: May 19, 2022
    Applicants: Keio University, Biomx Ltd.
    Inventors: Kenya HONDA, Koji ATARASHI, Seiko NARUSHIMA, Efrat KHABRA, Hava BEN DAVID, Eyal WEINSTOCK, Yulia MATIUHIN, Naomi Bluma ZAK
  • BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE
    Publication number: 20220031776
    Abstract: Disclosed herein are bacteriophage compositions and therapeutic uses thereof. The disclosure also relates to bacteriophage that are capable of lysing Klebsiella bacterial strains, e.g., strains that are associated with inflammatory bowel disease, and thereby capable of modulating disease.
    Type: Application
    Filed: September 7, 2018
    Publication date: February 3, 2022
    Inventors: Kenya Honda, Koji Atarashi, Seiko Narushima, Eran Elinav, Rotem Sorek, Efrat Khabra, Hava Ben David, Eyal Weinstock, Sarah Pollock, Yulia Matiuhin, Naomi Zak
  • Inhalable liquid formulations of DNase I
    Patent number: 9603906
    Abstract: An inhalable pharmaceutical composition for pulmonary administration comprising human DNase I and a liquid carrier and, more particularly, but not exclusively, to methods, liquid pharmaceutical inhalation devices and systems for the therapeutic use thereof are provided.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: March 28, 2017
    Assignee: Protalix Ltd.
    Inventors: Yoseph Shaaltiel, Uri Hanania, Tali Kizhner, Yulia Matiuhin, Liat Fux, Avidor Shulman
  • Dry powder formulations of dNase I
    Patent number: 9603907
    Abstract: DNase I formulations for pulmonary administration and, more particularly, but not exclusively, a dry powder formulation comprising, as an active ingredient, human DNase I, methods, dry powder inhalation devices and systems for the therapeutic use thereof are provided.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: March 28, 2017
    Assignee: Protalix Ltd.
    Inventors: Yoseph Shaaltiel, Uri Hanania, Tali Kizhner, Yulia Matiuhin, Liat Fux, Avidor Shulman
  • DRY POWDER FORMULATIONS OF DNASE I
    Publication number: 20150024050
    Abstract: DNase I formulations for pulmonary administration and, more particularly, but not exclusively, a dry powder formulation comprising, as an active ingredient, human DNase I, methods, dry powder inhalation devices and systems for the therapeutic use thereof are provided.
    Type: Application
    Filed: January 31, 2013
    Publication date: January 22, 2015
    Inventors: Yoseph Shaaltiel, Uri Hanania, Tali Kizhner, Yulia Matiuhin, Liat Fux, Avidor Shulman
  • INHALABLE LIQUID FORMULATIONS OF DNASE I
    Publication number: 20150010617
    Abstract: An inhalable pharmaceutical composition for pulmonary administration comprising human DNase I and a liquid carrier and, more particularly, but not exclusively, to methods, liquid pharmaceutical inhalation devices and systems for the therapeutic use thereof are provided.
    Type: Application
    Filed: January 31, 2013
    Publication date: January 8, 2015
    Inventors: Yoseph Shaaltiel, Uri Hanania, Tali Kizhner, Yulia Matiuhin, Liat Fux, Avidor Shulman
  • DNASE I POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, METHODS OF PRODUCING DNASE I AND USES THEREOF IN THERAPY
    Publication number: 20150010527
    Abstract: Plant-expressed human recombinant DNase proteins, nucleic acid constructs for expression of the human recombinant DNase I in plant cells, cells expressing the nucleic acid construct and therapeutic uses thereof are disclosed. Particularly, compositions and methods for treating pulmonary and/or respiratory conditions by inhalation of the plant-expressed human recombinant DNase I are provided.
    Type: Application
    Filed: January 31, 2013
    Publication date: January 8, 2015
    Inventors: Yoseph Shaaltiel, Uri Hanania, Tali Kizhner, Yulia Matiuhin, Liat Fux, Avidor Shulman